Skip to main content
. 2024 Aug 31;65(2):E172–E187. doi: 10.15167/2421-4248/jpmh2024.65.2.3329

Fig. 1.

Fig. 1.

Mechanism of action of Nirsevimab. A) Ø site of the PreF of the RSV fusion protein (F). B) The addition of the triple amino acid substitution M252Y/S254T/T256E (YTE) to the crystallisable region of the fragment (Fc).